Aspireo Reports Data in Further Phase Ib Study
Aspireo Pharmaceuticals Limited (“Aspireo”), an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited (“Aspireo”), an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited ("Aspireo"), an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited, ("Aspireo") an Israeli biopharmaceutical company, focused on the development of Somatop…
Aspireo Pharmaceuticals Limited, ("Aspireo") an Israeli biopharmaceutical company, focused on the development of Somatop…
Evotec AG (Frankfurter Wertpapierbörse: EVT, TecDAX) gab heute die Finanzergebnisse und die Geschäftsentwicklung für das…
. - Teaming up to partner Aspireo's Somatoprim (DG3173) Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX) and Aspir…
. - Zielsetzung ist die Kommerzialisierung von Somatoprim (DG3173) Evotec AG (Frankfurter Wertpapierbörse: EVT, Tec…